5W77

Solution structure of the MYC G-quadruplex bound to small molecule DC-34

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	0.3 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 25 mM D11- TRIS, 50 mM potassium chloride	90% H2O/10% D2O	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
2	2D 1H-1H NOESY	0.125 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.25 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% H2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
3	2D 1H-1H NOESY	0.25 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.50 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
4	2D 1H-1H NOESY	0.125 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.25 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% H2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 800
5	2D 1H-1H NOESY	0.25 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.50 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 800
6	2D 1H-1H TOCSY	0.125 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.25 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% H2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
7	2D 1H-1H COSY	0.125 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.25 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% H2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
8	2D 1H-1H TOCSY	0.25 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.50 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
9	2D 1H-1H COSY	0.25 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.50 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
10	3D 13C half-filtered NOESY	0.25 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.5 mM selective 13C-labeling (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850
11	2D 1H-1H TOCSY	0.5 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 700
12	2D 1H-1H NOESY	0.5 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 700
13	2D 1H-1H COSY	0.5 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 700
14	2D 1H-13C HSQC	0.5 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 700
15	2D 1H-13C HMBC	0.5 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% D2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 700
16	1D 1H	0.1 mM DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3'), 0.05-0.6 mM (2R)-4-[4-(3-methylphenyl)-1H-1,2,3-triazol-1-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine, 25 mM D11- TRIS, 50 mM potassium chloride	90% H2O/10% D6-DMSO	50 mM	6.4	1 atm	298.2	Bruker AVANCE 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	850
2	Bruker	AVANCE	800
3	Bruker	AVANCE	700

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.5pl5	Bruker Biospin
2	processing	NMRPipe	8.9	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	XEASY		Bartels et al.
4	peak picking	XEASY		Bartels et al.
5	data analysis	XEASY		Bartels et al.
6	data analysis	TALOS	TALOS+	Cornilescu, Delaglio and Bax
7	refinement	X-PLOR NIH	2.45	Schwieters, Kuszewski, Tjandra and Clore